bromocriptine has been researched along with thioridazine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH | 1 |
| Butler, DE; Coughenour, LL; DeWald, HA; Downs, DA; Heffner, TG; Lustgarten, D; Pugsley, TA; Wise, LD | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aronzon, R; Dorevitch, A; Stark, M | 1 |
| Goldwasser, HD; Hooper, JF; Spears, NM | 1 |
| Brust, J; Cohn, JB; DiSerio, F; Singer, J | 1 |
| Kern, PA; Robbins, RJ; Thompson, TL | 1 |
| Bunker, MT; Marken, PA; Ruehter, VL; Schneiderhan, ME | 1 |
| Freedman, MD | 1 |
| Alkin, T; Demopulos, CM; Ozerdem, A; Sagduyu, K; Yildiz, A | 1 |
2 review(s) available for bromocriptine and thioridazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Neuroleptic malignant syndrome and acute myocardial infarction: case report and review.
Topics: Antipsychotic Agents; Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Myocardial Infarction; Neuroleptic Malignant Syndrome; Thioridazine | 1997 |
11 other study(ies) available for bromocriptine and thioridazine
| Article | Year |
|---|---|
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection | 1991 |
(5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Ataxia; Avoidance Learning; Brain; Cebus; Chemical Phenomena; Chemistry; Dopamine; Male; Mice; Motor Activity; Movement Disorders; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Saimiri | 1986 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Psychotic exacerbation attributed to low-dose bromocriptine treatment of galactorrhea and hyperprolactinemia.
Topics: Acute Disease; Adult; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Psychoses, Substance-Induced; Schizophrenia, Paranoid; Thioridazine | 1991 |
Concomitant treatment of neuroleptic malignant syndrome and psychosis.
Topics: Adult; Bromocriptine; Creatine Kinase; Humans; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders; Thioridazine | 1989 |
Effect of bromocriptine mesylate on induced hyperprolactinemia in stabilized psychiatric outpatients undergoing neuroleptic treatment.
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Sex Factors; Thioridazine | 1985 |
Interactions between thioridazine and bromocriptine in a patient with a prolactin-secreting pituitary adenoma.
Topics: Adenoma; Adult; Bromocriptine; Drug Interactions; Humans; Male; Pituitary Neoplasms; Prolactin; Schizophrenia, Paranoid; Thioridazine; Tomography, X-Ray Computed; Visual Fields | 1984 |
Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
Topics: Adolescent; Amenorrhea; Antipsychotic Agents; Bromocriptine; Clozapine; Female; Fluphenazine; Galactorrhea; Haloperidol; Humans; Hyperprolactinemia; Prolactin; Psychotic Disorders; Thioridazine | 1997 |
Neuroleptic malignant syndrome: a case that may shed new light into the etiology and treatment.
Topics: Acute-Phase Proteins; Adult; Antipsychotic Agents; Bromocriptine; Clopenthixol; Dopamine Agonists; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome; Thioridazine | 2003 |